London
· Delayed Price · Currency is GBP · Price in EUR BRAIN Biotech AG Statistics
Total Valuation
LON:0RFI has a market cap or net worth of GBP 43.75 million. The enterprise value is 28.50 million.
| Market Cap | 43.75M |
| Enterprise Value | 28.50M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| PB Ratio | 5.13 |
| P/TBV Ratio | 5.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.75 |
| EV / Sales | 0.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.92 |
Financial Position
The company has a current ratio of 1.87
| Current Ratio | 1.87 |
| Quick Ratio | 0.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.34 |
Financial Efficiency
Return on equity (ROE) is -81.22% and return on invested capital (ROIC) is -39.07%.
| Return on Equity (ROE) | -81.22% |
| Return on Assets (ROA) | -8.19% |
| Return on Invested Capital (ROIC) | -39.07% |
| Return on Capital Employed (ROCE) | -15.90% |
| Revenue Per Employee | 155,942 |
| Profits Per Employee | -34,967 |
| Employee Count | 318 |
| Asset Turnover | 0.76 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.43% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -33.43% |
| 50-Day Moving Average | 3.03 |
| 200-Day Moving Average | 3.66 |
| Relative Strength Index (RSI) | 34.59 |
| Average Volume (20 Days) | 1,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0RFI had revenue of GBP 46.16 million and -10.35 million in losses. Loss per share was -0.47.
| Revenue | 46.16M |
| Gross Profit | 25.30M |
| Operating Income | -7.96M |
| Pretax Income | -10.33M |
| Net Income | -10.35M |
| EBITDA | -5.21M |
| EBIT | -7.96M |
| Loss Per Share | -0.47 |
Balance Sheet
The company has 14.74 million in cash and n/a in debt, giving a net cash position of 14.74 million.
| Cash & Cash Equivalents | 14.74M |
| Total Debt | n/a |
| Net Cash | 14.74M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.52M |
| Book Value Per Share | 0.39 |
| Working Capital | 14.31M |
Cash Flow
In the last 12 months, operating cash flow was -3.53 million and capital expenditures -1.28 million, giving a free cash flow of -4.81 million.
| Operating Cash Flow | -3.53M |
| Capital Expenditures | -1.28M |
| Free Cash Flow | -4.81M |
| FCF Per Share | n/a |
Margins
Gross margin is 54.80%, with operating and profit margins of -17.24% and -22.42%.
| Gross Margin | 54.80% |
| Operating Margin | -17.24% |
| Pretax Margin | -22.37% |
| Profit Margin | -22.42% |
| EBITDA Margin | -11.30% |
| EBIT Margin | -17.24% |
| FCF Margin | n/a |
Dividends & Yields
LON:0RFI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -23.66% |
| FCF Yield | -11.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |